Vyvanse 20 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FJL77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,805
Award facts
- Contract value 100% obligated
- $4,805.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,805.10 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive SPE2DX IDC functions as a global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Vyvanse, a controlled pharmaceutical product used primarily for attention deficit hyperactivity disorder treatment, exemplifies the routine pharmaceutical fulfillment activities conducted under AmerisourceBergen's expansive federal contract portfolio with DLA.
Quick answers
Who was awarded contract SPE2DB25FJL77?
SPE2DB25FJL77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FJL77 worth?
The government has obligated $4,805 on SPE2DB25FJL77.
Is contract SPE2DB25FJL77 an order under another contract?
Yes. SPE2DB25FJL77 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJL77 competed?
The extent of competition for SPE2DB25FJL77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award